Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia

The importance of neutropenia in the risk of serious infection in patients with cancer who are receiving cytotoxic chemotherapy was first recognized nearly 30 years ago 1 . Since then, considerable progress has been made in the management of fever and neutropenia in both adults and children, resulting in improved survival rates not only for these patients but also for other immunosuppressed patients, including those undergoing organ or bone marrow transplantation and those with bone marrow failure or human immunodeficiency virus (HIV) infection 2 , 3 . Some of the current principles for the management of fever in patients with neutropenia are outlined . . .